In this week’s View, Dr. Deepak Bhatt sits in for Dr. Eagle to discuss TIMING, a registry-based randomized controlled noninferiority study that examines early versus delayed non–Vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation, then looks at the Fingersture study on plaque histology and myocardial disease in sudden coronary death. Finally, Dr. Bhatt takes a look at a recent paper on evolving management concepts for left main coronary disease. Subscribe to Eagle’s Eye View